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Abstract
Background: Functional status and spinal mobility in patients with axial spondyloarthritis (axSpA) are known to be
determined both by disease activity and by structural damage in the spine. The impact of structural damage in the
sacroiliac joints (SIJ) on physical function and spinal mobility in axSpA has not been studied so far. The objective of
the study was to analyze the impact of radiographic sacroiliitis on functional status and spinal mobility in patients
with axSpA.
Methods: In total, 210 patients with axSpA were included in the analysis. Radiographs of SIJ obtained at baseline
and after 2 years of follow up were scored by two trained readers according to the modified New York criteria
grading system (grade 0–4). The mean of two readers’ scores for each joint and a sum score for both SIJ were
calculated for each patient giving a sacroiliitis sum score between 0 and 8. The Bath Ankylosing Spondylitis
Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI) at baseline and after 2 years
were used as outcome measures.
Results: Longitudinal mixed model analysis adjusted for structural damage in the spine (modified Stoke Ankylosing
Spondylitis Spine Score - mSASSS), disease activity (Bath Ankylosing Spondylitis Disease Activity Index - BASDAI and
C-reactive protein level) and gender, revealed an independent association of the sacroiliitis sum score with the
BASFI: b = 0.10 (95% CI 0.01–0.19) and the BASMI: b = 0.12 (95% CI 0.03–0.21), respectively, indicating that change by
one radiographic sacroiliitis grade in one joint is associated with BASFI/BASMI worsening by 0.10/0.12 points,
respectively, independently of disease activity and structural damage in the spine.
Conclusion: Structural damage in the SIJ might have an impact on functional status and spinal mobility in axSpA
independently of spinal structural damage and disease activity.
Trial registration: ClinicalTrials.gov, NCT01277419. Registered on 14 January 2011.
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Background
Axial spondyloarthritis (axSpA) covers both patients
with non-radiographic (nr) axSpA – often the earlier
stage of axSpA – and patients with radiographic axSpA,
also termed ankylosing spondylitis (AS). The latter is
defined by the presence of structural damage in the
sacroiliac joints (SIJ) on X-rays according to the modi-
fied New York criteria for AS. It was reported previously
that functional status and spinal mobility parameters in
patients with axSpA are independently determined by
irreversible structural damage in the spine, i.e. presence
of syndesmophytes and ankylosis, and by potentially
reversible disease activity [1–3]. At the same time, struc-
tural damage in the SIJ (such as erosions, joint space
alteration and especially ankylosis) might also have an
impact on mobility and function – a hypothesis that has
never been investigated in a wider range of the axSpA
spectrum including nr-axSpA and AS.
In the present work, we investigated the association
between structural damage in the SIJ and functional sta-
tus and spinal mobility in patients with axSpA.
Methods
Cohort description and patient selection
The present analysis used the data of the German
Spondyloarthritis Inception Cohort (GESPIC). A detailed
description of the latter has been reported previously
[4, 5]. Briefly, patients included in GESPIC were re-
quired to have a definite clinical diagnosis of axSpA
according to the treating rheumatologist with symptom
duration of up to 5 years for the non-radiographic form
and up to 10 years for the radiographic form (AS).
Patients with axSpA were classified as having AS if the
radiographic criterion of the modified New York Criteria
(presence of radiographic changes in the SIJ of at least
grade II bilaterally or at least grade III unilaterally) [6] was
fulfilled, and as having nr-axSpA otherwise. Overall, 210
patients were included in the present analysis based on
the availability of radiographs and clinical data at baseline
and after 2 years of follow up.
Clinical assessment
Clinical assessment was performed at baseline and every
6 months thereafter until year 2. Disease activity was
assessed by the Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI) [7] and level of C-reactive protein (CRP).
Functional status was assessed by the Bath Ankylosing
Spondylitis Functional Index (BASFI) [8] and spinal mobility
by the Bath Ankylosing Spondylitis Metrology Index
(BASMI) with an original 2-step method of calculation [9].
Radiographic assessment
Conventional anteroposterior pelvic radiographs and lat-
eral and anteroposterior cervical and lumbar spine
radiographs were obtained locally at baseline and after
2 years of follow up. Images were digitized if not avail-
able in digitized form, anonymized and subsequently
scored by two trained readers (DP and HH) who were
blinded to the time point of the investigation and to all
clinical data. Grading of radiographic sacroiliitis was per-
formed according to the established scoring system used
by the modified New York criteria for AS [6]:
 Grade 0 - normal
 Grade 1 - suspicious changes
 Grade 2 - minimal abnormality, small localized areas
with erosion or sclerosis, without alteration in the
joint width
 Grade 3 - unequivocal abnormality, moderate or
advanced sacroiliitis with one or more of: erosions,
evidence of sclerosis, widening, narrowing, or partial
ankylosis
 Grade 4 - severe abnormality, total ankylosis
Radiographic changes in hip joints were scored on
anteroposterior pelvic radiographs by the same readers
using the Bath Ankylosing Spondylitis Radiology Hip
Index (BASRI-hip) [10]. Structural damage in the spine
was assessed by the same blinded readers according to
the modified Stoke Ankylosing Spondylitis Spine Score
(mSASSS), as described in detail elsewhere [11].
Statistical analysis
For the current analysis, the mean of the scoring results
of the two readers was calculated for each sacroiliac
joint. Next, the sum of the two mean sacroiliitis scores
(left and right SIJ) was calculated for each patient result-
ing in a sacroiliitis sum score between 0 (no signs of
radiographic sacroiliitis in either SIJ in the opinion of
both readers) and 8 (total ankylosis in both SIJ in the
opinion of both readers) at baseline and after 2 years. To
visualize an association between BASFI/BASMI and the
sacroiliitis sum score, combined scatter and cumulative
probability plots were created.
The association between the sacroiliitis sum score and
BASFI/BASMI was explored first in the linear regression
analysis, which was performed with baseline values of
the variables of interest. Crude unstandardized param-
eter estimates (ß coefficients) obtained in the univariable
model were then adjusted in the multivariable model for
the following factors considered as potential con-
founders: structural damage in the spine (mSASSS), dis-
ease activity (BASDAI and CRP), and sex. In order to
address the question of the possible confounding of the
association between radiographic sacroiliitis and func-
tion/spinal mobility by the damage in the hip joints,
models with inclusion of the BASRI-hip as a covariate
were built.
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Next, linear regression analysis of the association
between change in BASFI/BASMI and progression of
radiographic sacroiliitis defined as (1) absolute change in
the sacroiliitis sum score, (2) worsening of radiographic
sacroiliitis by at least one grade in one sacroiliac joint in
opinion of both readers and (3) progression from nr-ax-
SpA to AS in the opinion of both readers was
performed.
At the final step, both baseline and year-2 parameters
were included in a longitudinal linear mixed model
analysis that was corrected for the dependencies
between the two time-point values of each individual.
Crude parameter estimates were adjusted for the same
potential confounders as in the linear regression analysis.
The latter analysis was performed in the entire group
and also separately in the non-radiographic and radio-
graphic subgroups of the patient population in order to
address the question of a possibly higher functional rele-
vance of the more advanced structural changes in the
SIJ; 95% confidence intervals (CIs) for the parameter
estimates were calculated. The inter-reader agreement
was assessed by means of the weighted Kappa value.
Statistical analysis was performed using SAS v.9.4 (SAS
Institute Inc., Cary, NC, USA).
Results
There were no major differences in general baseline
characteristics between the included patients (radio-
graphic cohort) and the whole previously described
cohort [4], except for a somewhat lower percentage of
men in the nr-axSpA subgroup (33.7% in the current
study vs 42.9% in the whole cohort). General character-
istics of the patients at baseline are presented in Table 1.
Detailed results of the assessment of the SIJ on pelvic
radiographs including inter-reader variability and change
over time have been reported previously [5, 12]. Briefly,
based on the baseline assessment of the SIJ, 115 out of
210 patients were classified as having AS, and 95 as hav-
ing nr-axSpA. The sacroiliitis sum score distribution at
baseline and change in the sacroiliitis sum score after
2 years of follow up are presented in Fig. 1. The mean
sacroiliitis sum score at baseline was 4.3 ± 2.0 and the
mean change in the sacroiliitis sum score over 2 years
was 0.13 ± 0.84. In the entire group of 210 patients, a
total of 26 patients (12.4%) had progression of radio-
graphic sacroiliitis by at least one grade after 2 years in
the opinion of both readers (16.8% of patients with
nr-axSpA and 8.7% of patients with AS). Improvement
in radiographic sacroiliitis by at least one grade in the
opinion of both readers was observed in 11 patients
(5.2%) in the entire group (6.3% and 4.4% of patients
with nr-axSpA and AS, respectively). Progression from
nr-axSpA to AS after 2 years was observed in the opin-
ion of both readers in 11 out of 95 patients (11.6%), and
regression from AS to nr-axSpA was observed in 3 out
of 115 patients (2.6%).
There was moderate agreement between the two
readers on the fulfilment of the modified New York
criteria (weighted Kappa value 0.59 at baseline, and 0.67
and after 2 years of follow up) and on the grade of radio-
graphic sacroiliitis (weighted Kappa values between 0.51
and 0.59 for the left and right SIJ at baseline and year 2)
[5]. The combined cumulative probability and scatter
plots on Fig. 2 depict the crude relationship between the
sacroiliitis sum score and BASFI (Fig. 2a) or BASMI
(Fig. 2b).
In the univariable linear regression models, the crude
parameter estimates (ß) for the association between
sacroiliitis sum score and BASFI/BASMI at baseline
were 0.09 (95% CI -0.07 to 0.25) and 0.22 (95% CI 0.12
to 0.33), respectively. After adjustment for the mSASSS,
disease activity parameters (BASDAI and CRP), and sex,
ß changed to 0.10 (95% CI -0.01 to 0.21) and 0.12 (95%
CI 0.01 to 0.22), respectively. These parameter estimates
indicate that difference in one sacroiliitis grade is
responsible for the difference in 0.10/0.12 points on the
BASFI/BASMI, respectively. Adding the BASRI-hip




AS (n = 115) All patients
(n = 210)
Age, years 38.7 ± 9.9 36.8 ± 11.0 37.3 ± 10.6
Male gender, n (%) 32 (33.7) 75 (65.2) 107 (51.0)
HLA-B27 positive, n (%) 69 (72.6) 97 (84.3) 166 (79.0)
Duration of symptoms,
years
3.2 ± 2.2 5.2 ± 2.8 4.2 ± 2.7
BASDAI, points NRS
(0–10)
4.2 ± 2.0 3.8 ± 2.2 3.9 ± 2.2
Peripheral arthritis, n (%) 16 (16.8) 15 (13.0) 31 (14.8)
BASFI, points NRS (0–10) 2.8 ± 2.2 3.0 ± 2.4 2.9 ± 2.3
BASMI, points (0–10) 1.5 ± 1.5 2.0 ± 1.7 1.8 ± 1.6
CRP, mg/l 6.5 ± 12.8 12.4 ± 16.6 9.7 ± 15.2
mSASSS, points (0–72) 2.3 ± 4.2 5.9 ± 10.3 4.2 ± 8.3
NSAIDs intake, n (%) 64 (67.4) 76 (66.1) 140 (66.7)
Systemic steroids intake,
n (%)
6 (6.3) 6 (5.2) 12 (5.7)
DMARDs intake, n (%) 26 (27.4) 35 (30.4) 61 (29.0)
TNFα blocker intake,
n (%)
1 (1.1) 4 (3.5) 5 (2.4)
Current smoking, n (%) 24 (25.3) 39 (33.9) 63 (30.0)
Continuous variables are presented as mean ± standard deviation
AS ankylosing spondylitis, BASDAI Bath Ankylosing Spondylitis Disease Activity
Index, BASFI Bath Ankylosing Spondylitis Functional Index, BASMI Bath
Ankylosing Spondylitis Metrology Index, CRP C-reactive protein, DMARDs
disease-modifying anti-rheumatic drugs, mSASSS modified Stoke Ankylosing
Spondylitis Spine Score, nr-axSpA non-radiographic axial spondyloarthritis, NRS
numeric rating scale, NSAIDs non-steroidal anti-inflammatory drugs, TNFα
tumour necrosis factor alpha
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score as an additional potential confounder in the
models did not substantially affect the parameter esti-
mates for either functional outcome (ß = 0.11, 95% CI
-0.01 to 0.23 and 0.13, 95% CI 0.02 to 0.24 for BASFI
and BASMI, respectively), therefore, this variable was
not included in further analysis.
In the linear regression analysis of the association
between BASFI/BASMI change scores over 2 years with
the absolute change in the sacroiliitis sum score, ß was
0.03 (95% CI -0.19 to 0.25) and 0.25 (95% CI 0.03 to
0.47), respectively, adjusted for the mSASSS change
score, BASDAI change score, time-averaged CRP over
two years, and sex.
Worsening of radiographic sacroiliitis by at least one
grade in the opinion of both readers was assessed in a
similar analysis, with ß of -0.13 (95% CI -0.69 to 0.42)
and 0.64 (95% CI 0.09 to 1.19), for BASFI and BASMI,
respectively. Progression from nr-axSpA to AS after
2 years was assessed in 95 patients classified as having
nr-axSpA at baseline, with ß of 0.79 (95% CI -0.06 to
1.65) and 0.49 (95% CI -0.04 to 1.35), for BASFI and
BASMI, respectively.
In the longitudinal mixed model analysis (Table 2) that
included values obtained at both time points (baseline
and year 2) with correction for dependencies between
two values related to the same patient, the sacroiliitis
sum score demonstrated stronger association with the
BASMI than with the BASFI, with ß = 0.20 (95% CI 0.11
to 0.30) and 0.09 (95% CI -0.05 to 0.22), respectively, in
the univariable analysis. However, after adjustment for
Fig. 1 Distribution of the sacroiliitis sum score at baseline (a) and change in the sacroiliitis sum score over 2 years (b) in 210 patients with
axial spondyloarthritis
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the mSASSS, disease activity parameters (BASDAI and
CRP) and gender, the strength of association became
very similar for both outcomes: ß = 0.10 (95% CI 0.01 to
0.19) for BASFI and ß = 0.12 (95% CI 0.03 to 0.21) for
BASMI, indicating that progression by one radiographic
sacroiliitis grade would result in a change of 0.10/0.12
points in the BASMI/BASFI. Therefore, progression
from grade 0 bilaterally to grade 2 bilaterally or grade 4
bilaterally would result in an increase of 0.40/0.48 or
0.80/0.96 points on the BASFI/BASMI, respectively,
independently of structural damage in the spine and dis-
ease activity.
Fig. 2 Combined cumulative probability and scatter plots depicting an association between the sacroiliitis sum score and the Bath Ankylosing
Spondylitis Functional Index (BASFI) (a) or the Bath Ankylosing Spondylitis Metrology Index (BASMI) (b) at baseline in 210 patients with
axial spondyloarthritis
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Similar analysis performed in the AS and nr-axSpA
subgroups resulted in similar results, though the preci-
sion of the parameter estimation decreased due to the
smaller group size (Table 2).
Discussion
In this work, we showed that structural damage in the
SIJ might have an impact, although small, on spinal
mobility and physical function in patients with axSpA,
independently of other parameters, such as disease activ-
ity and structural damage in the spine. To our know-
ledge, this is the first study that addresses this question
in a population of patients with axSpA including non-
radiographic and radiographic axSpA (i.e., the full range
of radiographic sacroiliitis) and using standardized mea-
sures of spinal mobility and functional status assessment
– BASMI and BASFI.
Only a few studies have investigated the potential
impact of radiographic sacroiliitis on mobility and func-
tional status in patients with axSpA or AS. In a study by
Kennedy et al., an association between BASMI score and
total radiological score (incorporating the radiographic
grade of sacroiliitis) in patients with AS was shown,
although the association between radiographic sacroilii-
tis and spinal mobility measures, regardless of spinal
damage, was not investigated [13]. A study by Viitanen
et al. showed correlation between radiographic changes
in the lumbar spine and in the SIJ and spinal mobility
measures, but again the effect of radiographic sacroiliitis
alone was not estimated [14]. Taylor et al. also observed
correlation between spinal flexion and the SIJ ankylosis
score assessed on computed tomography that was, how-
ever, not adjusted for any confounders [15]. In a study in
reactive arthritis (Reiter’s syndrome) radiographic sacroi-
liitis was found to be mostly asymptomatic and func-
tionally irrelevant, but no standardized methods of
spinal mobility and functional status assessment were
used [16]. A more recent population-based study revealed
no difference in the patient-reported outcome between
subjects with and without radiographic sacroiliitis, but
again, no standardized methods of spinal mobility and
functional status assessment were used, and the number
of cases with sacroiliitis was small (n = 14) [17].
Several studies investigated the influence of artificial
SIJ ankylosis on spinal mobility. For example, no differ-
ence was identified between patients who underwent
unilateral and bilateral transsacral-transiliac screw fix-
ation in terms of functional status, indicating that artifi-
cial ankylosis of the second SIJ does not reduce the
functional parameters (although the outcome was not an
objective measurement, but rather a self-reported out-
come) [18]. Comparison of quality of life and perform-
ance in patients who underwent unilateral SIJ fusion
showed results comparable with the average health
Table 2 Association between the sum radiographic sacroiliitis score and functional status/spinal mobility in patients with axial
spondyloarthritis
Parameters Unadjusted mixed model
analysis (all patients, n = 210),
B (95% CI)
Adjusted mixed model analysis
(all patients, n = 210), B (95% CI)
Adjusted mixed model analysis
(patients with AS, n = 105), B
(95% CI)
Adjusted mixed model analysis





0.09 (-0.05 to 0.22) 0.10 (0.01 to 0.19) 0.16 (-0.03 to 0.36) 0.09 (-0.11 to 0.30)
mSASSS, points
(0–72)
- 0.05 (0.03 to 0.07) 0.04 (0.02 to 0.06) 0.08 (0.03 to 0.14)
BASDAI, points
NRS (0–10)
- 0.81 (0.74 to 0.88) 0.84 (0.74 to 0.93) 0.75 (0.63 to 0.86)
CRP, mg/l - 0.00 (-0.01 to 0.01) 0.00 (-0.01 to 0.01) 0.00 (-0.02 to 0.01)




0.20 (0.11 to 0.30) 0.12 (0.03 to 0.21) 0.17 (-0.02 to 0.37) 0.21 (0.01 to 0.40)
mSASSS, points
(0–72)
- 0.07 (0.05 to 0.09) 0.07 (0.04 to 0.09) 0.04 (-0.01 to 0.10)
BASDAI, points
NRS (0–10)
- 0.22 (0.15 to 0.29) 0.23 (0.14 to 0.32) 0.18 (0.07 to 0.30)
CRP, mg/l - 0.01 (0.00 to 0.02) 0.01 (0.00 to 0.03) 0.00 (-0.03 to 0.01)
Male sex - 0.00 (-0.39 to 0.39) 0.32 (-0.21 to 0.85) -0.35 (-0.92 to 0.22)
mSASSS modified Stoke Ankylosing Spondylitis Spine Score, AS Ankylosing Spondylitis, nr-axSpA non-radiographic axial spondyloarthritis, BASFI Bath Ankylosing
Spondylitis Functional Index, CRP C-reactive protein, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, NRS numerical rating scale, BASMI Bath Ankylosing
Spondylitis Metrology Index
Main results are marked in bold
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status of the US population, indicating no significant in-
fluence of unilateral SIJ fusion on functional perform-
ance [19]. Importantly, SIJ fusion is normally performed
in symptomatic patients with mechanical problems in
the SIJ and even an improvement in function and spinal
mobility could be expected due to pain reduction as an
outcome of the intervention.
In our analysis, both cross-sectional and longitudinal
models showed a rather small but significant and inde-
pendent association between radiographic sacroiliitis and
spinal mobility/function in patients with axSpA (though
the precision of the effect estimation was better in the
longitudinal model), indicating that progression from
normal (without structural damage visible on radiographs)
SIJ to complete bilateral ankylosis would result in a
worsening of the BASFI/BASMI by about 1 point (on a 0
− 10 scale), independently of disease activity and structural
damage in the spine. For comparison, worsening of the
mSASSS score by 1 point (on a scale between 0 and 72)
has been reported to result in worsening of the BASFI by
0.06 points, independently of the BASDAI [2].
We hypothesize several explanations for our findings.
The first possible explanation would be that the
observed independent association between structural
damage in the SIJ and spinal mobility/functional status
is real. In this case, we have to postulate that the SIJs are
indeed relevant for spinal mobility, and structural dam-
age in these joints results in lower function. If so, stop-
ping structural damage in the SIJ might become an
additional treatment target in axSpA aiming at preserva-
tion of the spinal mobility/functional status in axSpA in
a long-term perspective. Nevertheless, a benefit/risk
assessment of intensified treatment would be necessary
in this case.
An alternative explanation might be related to the fact
that the mSASSS score takes into account only struc-
tural damage involving the anterior corners of the cer-
vical and lumbar vertebrae. Although mSASSS is
considered to be a proxy for the structural damage in
the entire spinal column, the fact that assessment of
damage to the spinal structures is not included in the
mSASSS (i.e. the posterior structures, thoracic spine)
might be responsible for the residual confounding caus-
ing a significant association between radiographic sacroi-
liitis and the BASFI/BASMI after adjustment for the
mSASSS. We also cannot exclude residual confounding
related to other factors, which were not captured and
therefore not included in the analysis (e.g. effects of
inflammation in the spine as detected by magnetic res-
onance imaging, which was not performed in GESPIC in
the first 2 years).
The clinical significance of our findings is ambiguous.
On the one hand, the results expressed in absolute num-
bers (the change in one sacroiliitis grade in one of the
joints is associated with a change of 0.10/0.12 points in
the BASFI/BASMI, respectively) seem quite modest,
especially considering that the rate of radiographic pro-
gression is slow [5, 20–22]. On the other hand, this asso-
ciation is independent from the other factors, somewhat
higher than expected and, if true, alongside with other
factors it might be a significant contribution to the
deterioration of physical function in the long run.
Conclusion
Data from GESPIC indicate that structural damage in
the SIJ might have an impact on functional status and
spinal mobility independently of structural damage in
the spine and disease activity in patients with axSpA –
an association that has been mostly neglected
previously.
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